Editor's Choice–2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery …
Document Reviewers b, Petr Widimsky, Philippe Kolh, Stefan Agewall, Héctor Bueno,
Antonio Coca, Gert J. De Borst, Victoria Delgado, Florian Dick, Cetin Erol, Marc Ferrini …
Antonio Coca, Gert J. De Borst, Victoria Delgado, Florian Dick, Cetin Erol, Marc Ferrini …
The current state of critical limb ischemia: a systematic review
A Farber, RT Eberhardt - JAMA surgery, 2016 - jamanetwork.com
Importance Chronic critical limb ischemia, marked by intractable lower extremity ischemic
rest pain and tissue loss, is a highly morbid condition that leads to the loss of ambulation …
rest pain and tissue loss, is a highly morbid condition that leads to the loss of ambulation …
[PDF][PDF] 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
W 2011 roku ESC opublikowało pierwsze wytyczne dotyczące rozpoznawania i leczenia
chorób tętnic obwodowych (PAD)[1]. Ta publikacja wypełniła ważną lukę wśród wytycznych …
chorób tętnic obwodowych (PAD)[1]. Ta publikacja wypełniła ważną lukę wśród wytycznych …
Cell therapy of peripheral arterial disease: from experimental findings to clinical trials
Z Raval, DW Losordo - Circulation research, 2013 - Am Heart Assoc
The age-adjusted prevalence of peripheral arterial disease in the US population was
estimated to approach 12% in 1985, and as the population ages, the overall population …
estimated to approach 12% in 1985, and as the population ages, the overall population …
[HTML][HTML] Diabetic foot infections: what have we learned in the last 30 years?
I Uçkay, J Aragon-Sanchez, D Lew… - International Journal of …, 2015 - Elsevier
Background Infection is a common epiphenomenon of advanced diabetic foot disease and
the most common reason for diabetes-related hospitalizations and lower extremity …
the most common reason for diabetes-related hospitalizations and lower extremity …
The effect of aging on the cutaneous microvasculature
I Bentov, MJ Reed - Microvascular research, 2015 - Elsevier
Aging is associated with a progressive loss of function in all organs. Under normal
conditions the physiologic compensation for age-related deficits is sufficient, but during …
conditions the physiologic compensation for age-related deficits is sufficient, but during …
Vascular regeneration in peripheral artery disease
JP Cooke, S Meng - Arteriosclerosis, thrombosis, and vascular …, 2020 - Am Heart Assoc
Peripheral artery disease is a common disorder and a major cause of morbidity and mortality
worldwide. Therapy is directed at reducing the risk of major adverse cardiovascular events …
worldwide. Therapy is directed at reducing the risk of major adverse cardiovascular events …
TIE2‐expressing monocytes/macrophages regulate revascularization of the ischemic limb
AS Patel, A Smith, S Nucera, D Biziato… - EMBO molecular …, 2013 - embopress.org
A third of patients with critical limb ischemia (CLI) will eventually require limb amputation.
Therapeutic neovascularization using unselected mononuclear cells to salvage ischemic …
Therapeutic neovascularization using unselected mononuclear cells to salvage ischemic …
Prostanoids for critical limb ischaemia
V Vietto, JVA Franco, V Saenz, D Cytryn… - Cochrane Database …, 2018 - cochranelibrary.com
Background Peripheral arterial occlusive disease (PAOD) is a common cause of morbidity
and mortality due to cardiovascular disease in the general population. Although numerous …
and mortality due to cardiovascular disease in the general population. Although numerous …
Vasculogenic conditioning of peripheral blood mononuclear cells promotes endothelial progenitor cell expansion and phenotype transition of anti‐inflammatory …
H Masuda, R Tanaka, S Fujimura… - Journal of the …, 2014 - Am Heart Assoc
Background Cell‐based therapies involving mononuclear cells (MNC s) have been
developed for vascular regeneration to treat ischemic diseases; however, quality control of …
developed for vascular regeneration to treat ischemic diseases; however, quality control of …